Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001225926 | SCV001398220 | uncertain significance | Fanconi anemia | 2022-08-16 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 13 of the FANCA gene. It does not directly change the encoded amino acid sequence of the FANCA protein. This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FANCA-related conditions. ClinVar contains an entry for this variant (Variation ID: 953609). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002504293 | SCV002815670 | uncertain significance | Fanconi anemia complementation group A | 2022-01-10 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003478741 | SCV004221908 | uncertain significance | not provided | 2022-08-09 | criteria provided, single submitter | clinical testing | The variant has not been reported in the published literature. The frequency of this variant in the general population, 0.0002 (5/24938 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant may affect proper FANCA mRNA splicing . Based on the available information, we are unable to determine the clinical significance of this variant. |
Natera, |
RCV001225926 | SCV002095058 | uncertain significance | Fanconi anemia | 2020-09-23 | no assertion criteria provided | clinical testing |